Abogen Biosciences

formerly Abogen

Unlocking the mRNA technology for life-saving therapeutics

Suzhou, China · Founded 2019 · $1.2B raised

Headquarters
Suzhou
Employees
201–500
Founded
2019
Business Model
B2B
Total Funding
$1.2B
Last Round
$300.0M Extension RoundNov 2021
Rounds
5

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Abogen Biosciences is China's leading fully integrated mRNA medicines company, with proprietary platforms spanning mRNA sequence design, lipid nanoparticle (LNP) delivery, and scalable GMP manufacturing. Its Dynamic Precision Mixing (DPM) technology and ionizable lipid library have been validated in global Phase III trials enrolling 30,000+ participants. The company's pipeline spans immuno-oncology, autoimmune diseases, and infectious disease vaccines, with AI integrated across every development stage.

Summary

Abogen Biosciences is a Biotech company based in Suzhou, China, founded in 2019. It has raised $1.2B in total across 5 rounds, most recently a $300.0M Extension Round in Nov 2021. Investors include SoftBank, 5Y Capital and GL Ventures.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Extension RoundSeries C+Nov 2021
$300.0M

Sign up to see all 5 events

Funding: Pre-Seed through Extension Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

OricIPO

San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...

South San Francisco, United States51–200Biotech, Healthcare
Private EquityTotal funding$647.0MFeb 2026
Neumora TherapeuticsIPO

Clinical-stage biopharmaceutical developing precision medicines targeting novel mechanisms to tre...

Watertown, United States51–200Biotech, Drug Discovery
Series BTotal funding$612.0MOct 2022
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Paratek PharmaceuticalsAcquired

Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...

Boston, United States201–500Biotech, Healthcare
ConvertibleTotal funding$1.8BApr 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020
Eikon TherapeuticsIPO

Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...

Hayward, United States201–500Artificial Intelligence, Biotech
Series DTotal funding$1.1BFeb 2025

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Abogen Biosciences on Indexed.vc
<a href="https://indexed.vc/companies/abogen-biosciences"><img src="https://indexed.vc/api/badge/company/abogen-biosciences" alt="Abogen Biosciences on Indexed.vc" width="260" height="76" /></a>